Exchange Announcement • 06 Dec 2025 06:29
Exchange Announcement • 06 Dec 2025 06:07
Exchange Announcement • 05 Dec 2025 19:01
Exchange Announcement • 05 Dec 2025 05:30
Exchange Announcement • 03 Dec 2025 22:29
Search or
𝛼SK
𝛼SKENTITY
Capricor Therapeutics (CAPR US)
Capricor Therapeutics (CAPR US)
5
Analysis
Health Care • United States
Capricor Therapeutics, Inc. operates as a clinical stage biotechnology company. The Company focuses on the development and commercialization of biological therapies for the treatment of duchenne muscular dystrophy (DMD) and other rare disorders. Capricor Therapeutics serves healthcare sector in the United States and Canada.
morex